Hosted by the Digital Medicine Society (DiMe), the Digital Health Measurement Collaborative Community (DATAcc) will use interdisciplinary expertise, data, and use cases to develop and demonstrate best practices and advance harmonized approaches to speed the use of digital health measurement to improve health outcomes, health economics, and health equity.
DiMe has brought together the many stakeholders necessary to establish and implement a shared vision of high quality digital health measurement that is available to and effective for every person. VivoSense is excited to be one of the 2021-2022 DATAcc Steering Committee member organizations.
DiMe is a global non-profit and the professional home for all members of the digital medicine community.
VivoSense has joined DiMe's digital clinical measures projects Core Measures of Sleep, and the Physical Activity Project. In partnership with the Digital Medicine Society and other leaders in the field, we are paving the way for better approaches to collecting, analyzing, and interpreting sleep data.
VivoSense has joined The Decentralized Trials & Research Alliance (DTRA), an alliance of over one hundred and twenty life sciences and healthcare organizations that seek to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. They are uniting industry stakeholders, including healthcare companies, regulators, patient groups, research organizations and technology providers with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices and new technologies in decentralized clinical research.
VivoSense, Inc. has joined the Clinical Trials Transformation Initiative (CTTI) to advance the efficiency and efficacy of clinical trial research and care. As a leading provider of digital endpoint solutions derived from wearable sensors, VivoSense will contribute to CTTI's foundational efforts to improve quality, patient engagement, novel trial design, digital health trials, investigator, and site support and ethics in research.
The Foundation for the National Institutes of Health (FNIH) connects the world’s leading public and private organizations to accelerate biomedical breakthroughs for patients, regardless of who they are, where they live or what disease they have. Together with leading scientists and problem-solvers, and a successful track record of navigating complex problems, the FNIH accelerates new therapies, diagnostics, and potential cures; advances global health and equity in care; and celebrates and trains the next generation of scientists
On June 2, 2023, at ASCO, CancerX, a public-private partnership co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe), along with the Office for the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), announced its founding members. VivoSense is proud to be among other organizations striving to eradicate cancer!
VivoSense is a data analysis consulting and software company specializing in wearable sensor physiological monitoring solutions for healthcare research and clinical trials. The following innovative types of organizations can partner with us to use or resell our software and services to improve therapies, medications, and patient outcomes.
Wearable sensors & device manufacturers, and platform and software companies.
Contract Research Organizations delivering wearable solutions in clinical trials.
Organizations that provide outsourced specialized skills to clinical researchers.
Disease-specific, academic groups aimed at building new solutions for healthcare.
